v3.25.1
Commitments and Contingencies (Tables)
6 Months Ended
Mar. 31, 2025
Commitments and Contingencies Disclosure [Abstract]  
Schedule of operating lease costs
               
    Three months ended March 31,   Six months ended March 31,
    2025   2024   2025   2024
Operating lease costs   $ 33     $ 31     $ 66     $ 61  
Schedule of contributions under the plan
               
    Three Months Ended March 31,   Six Months ended March 31
    2025   2024   2025   2024
Contributions to 401(k) plan   $ 67     $ 94     $ 115     $ 167  
Schedule of stock option activity
                                 
    Number of Options   Weighted Average Exercise Price
($)
  Weighted Average Grant Date Fair Value
($)
  Aggregate intrinsic value
($)
Outstanding, September 30, 2024       15,037,754       6.80       5.12       15,825,791  
Granted       1,483,500       8.58       6.22        
Exercised       (820,632 )     2.46       1.89       6,785,518  
Outstanding, March 31, 2025       15,700,622       7.19       5.39       38,630,198  
Exercisable, March 31, 2025       10,346,086       6.03       4.68       34,276,704  
Schedule of summarizes information about stock options
                                                   
Range of exercises prices   Number of outstanding   Weighted average remaining contractual life (in   Weighted average exercise   Number of vested   Weighted average exercise
From   To    options   years)      price    options     price
$ 0.92     $ 3.00       2,400,150       3.92     $ 2.69       2,400,150     $ 2.69  
$ 3.01     $ 5.00       2,197,500       3.44     $ 3.41       2,027,916     $ 3.31  
$ 5.01     $ 9.00       8,028,972       6.36     $ 6.95       4,297,519     $ 6.39  
$ 9.01     $ 13.00       1,609,000       6.81     $ 10.29       998,834     $ 10.42  
$ 13.01     $ 25.00       1,465,000       5.97     $ 18.18       621,667     $ 18.34  
                  15,700,622       5.59     $ 7.19       10,346,086     $ 6.03  
Schedule of general and administrative expenses and research and development expenses
                               
    Three months ended March 31,   Six months ended March 31,
    2025   2024   2025   2024
General and administrative   $ 605     $ 979     $ 1,407     $ 1,905  
Research and development     844       1,673       2,097       3,033  
Total share-based compensation   $ 1,449     $ 2,652     $ 3,504     $ 4,938  
Schedule of weighted average assumptions for fair value of each option award
               
    2025   2024
Risk-free interest rate     3.98 %     4.28 %
Expected life of options (years)     5.56       5.74  
Annualized volatility     86.49 %     84.84 %
Dividend rate     0.00 %     0.00 %